Israel Active

Researchers at Israel's Sheba Medical Center and Intel have achieved 81% accuracy in predicting if biologic therapy would relieve a patient with Crohn’s Disease. They used machine-learning to analyze videos of complete capsule endoscopies (CE) of the small intestine.

Researchers at Haifa University have identified a blood test to diagnose patients who suffer from bipolar disorder. The test also can predict if the patient will respond to the most common treatment – Lithium carbonate. It can save misdiagnosis and wrong medication.

Israeli biotech ExoProTher is developing an anti-cancer therapy using protein generated from the p53 gene in the corneas of chickens. The foreign protein binds to cancerous human p53 protein, destroying tumors without side effects. The cornea is highly cancer resistant and full of p53 protein.

Israel’s Trisol Medical (see previously) has successfully implanted its new Transcatheter Tricuspid Valves in two US patients. The valve is called “forgotten” as the aortic and mitral valves get most medical attention. 10 Israelis have already had the implants.

Researchers at the Hebrew University of Jerusalem and Israel’s Technion Institute have created a tiny functioning human heart, smaller than a grain of rice. It will help scientists study the heart and develop new treatments for cardio-vascular diseases.  

Surgeons at Jerusalem’s Hadassah Ein Kerem detected twisted fallopian tubes in a fetus during a routine ultrasound of the mother. They immediately delivered the baby and performed a complex operation to save her ovaries.

Israeli NGOs IsraAID and Save A Child’s heart returned to South Sudan to assess children who needed heart surgery (see previously). They screened 74 children including 4-year-old Gladys who was in urgent need. Gladys was rushed to Israel for surgery.

Israel’s ELGAN (see previously) has been awarded a $2.5 million grant by the European Innovation Council (EIC). It will help ELGAN clinically test its ELGN-GI oral formula for the treatment of intestinal malabsorption that prevents preterm infants from absorbing nutrients.

Doctors at Israel’s Sheba Medical Center have developed AISAP POCAD (AI Point of Care Assisted Diagnosis) to diagnose a patient’s cardiac problem As Soon As Possible. The AI system uses any manufacturer’s supplied combination of handheld ultrasound probe and digital tablet.

Israeli-founded Bionaut Labs (see previously) has safety-tested its micro robot containing a magnet, that can travel via spinal fluid, directly to the brain, to deliver therapy or perform surgery. It can also navigate to any part of the body. Bionaut plans to begin human trials in late 2024.